June 28, 2026 a 11:43 am
GILD: Fundamental Ratio Analysis - Gilead Sciences, Inc.
Gilead Sciences demonstrates a robust presence in the biopharmaceutical sector, delivering treatments across various critical health areas. Recent assessments indicate a stable performance with potential for growth, particularly in its innovative therapies segment. However, investors should remain vigilant concerning market volatility and competitive pressures.
Fundamental Ratings
The fundamental rating of Gilead Sciences is strong, reflecting solid returns and some challenges with debt and pricing.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Historical data shows how Gilead's scores have changed over time, providing insights into its past performance.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-25 | 3 | 5 | 5 | 5 | 1 | 2 | 1 |
| Previous | 0 | 5 | 5 | 5 | 1 | 2 | 1 |
Analyst Price Targets
Analysts provide price targets indicating potential stock movement, but consensus suggests a "Buy".
| High | Low | Median | Consensus |
|---|---|---|---|
| $180 | $122 | $165 | $161.81 |
Analyst Sentiments
The analyst sentiment is generally positive, with a majority favoring a "Buy" recommendation.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 38 | |
| Hold | 19 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Gilead Sciences exhibits a stable fundamental backdrop with a noteworthy product portfolio contributing to reliable returns on equity and assets. While debt levels and pricing ratios present some challenges, the company's innovative capabilities and significant market presence may bolster long-term prospects. Analysts maintain a favorable outlook, suggesting promising future performance under stable market conditions.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years